Transient Ischemic Attack News and Research

RSS

A transient ischemic attack (TIA) is a transient stroke that lasts only a few minutes. It occurs when the blood supply to part of the brain is briefly interrupted. TIA symptoms, which usually occur suddenly, are similar to those of stroke but do not last as long. Most symptoms of a TIA disappear within an hour, although they may persist for up to 24 hours. Symptoms can include: numbness or weakness in the face, arm, or leg, especially on one side of the body; confusion or difficulty in talking or understanding speech; trouble seeing in one or both eyes; and difficulty with walking, dizziness, or loss of balance and coordination.

Study sheds light on link between higher BMI and serious health outcomes, death

A new study has shed light on the link between higher body mass index and serious health outcomes and death in over 2.8 million adults representative of the UK population.

29 Apr 2019

Rheumatoid arthritis patients likely to experience cardiovascular benefits from statins

Results from a large clinical trial indicate that patients with rheumatoid arthritis are likely to experience the same level of cardiovascular benefits from statins as other individuals, without additional risks.

15 Apr 2019

Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack

Patients given clot busters to treat a heart attack fared equally well if they were given the standard blood thinning medication clopidogrel versus the newer, more potent drug ticagrelor, according to research presented at the American College of Cardiology's 68thAnnual Scientific Session.

19 Mar 2019

Specific beliefs of stroke survivors have the power to lower blood pressure

Stroke survivors who believe they can protect themselves from having another stroke had more than twice the blood pressure reduction of nonbelievers, according to preliminary research to be presented in Honolulu at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.

30 Jan 2019

Study highlights need for reliable therapeutic targets for prevention, treatment of cardiovascular diseases

CVD (cardiovascular diseases) are proven to be the leading cause of deaths throughout the world. If statistics are reviewed, almost four out of five deaths are due to myocardial infarction or stroke.

21 Jan 2019

UC researchers receive $3.2 million grant to study stroke recurrence risk

Researchers at the University of Cincinnati have received a $3.2 million grant from the National Institute of Neurological Diseases to study the use of neuroimaging to pinpoint the risk factors of stroke recurrence.

7 Jan 2019

Using untargeted metabolomics to find biomarkers and therapeutic targets for CVD

Cardiovascular diseases are proven to be the leading cause of deaths throughout the world. If statistics are reviewed, almost four out of five deaths are due to myocardial infarction or stroke. Efforts to prevent CVD have little effect on the decrease of the number of CVD related deaths despite many medical advances.

26 Dec 2018

Statins associated with low risk of side effects

The cholesterol-lowering drugs called statins have demonstrated substantial benefits in reducing the risk of heart attacks and strokes caused by blood clots (ischemic strokes) in at-risk patients.

10 Dec 2018

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S announced study results on the safety and efficacy of brexpiprazole in the treatment of patients with schizophrenia experiencing severe psychotic symptoms during an acute episode. The data will be presented at the upcoming Psych Congress, held in Orlando from October 25-28, 2018.

26 Oct 2018

11th World Stroke Congress examines high stroke impact in low- and middle-income countries

11th World Stroke Congress brings together leading international stroke experts and an unparalleled scientific program covering epidemiology, prevention, acute care, recovery and rehabilitation in 100s of sessions and oral posters.

22 Oct 2018

Incidence of stroke has risen steadily among marijuana users, show studies

11th World Stroke Congress brings together leading international stroke experts and an unparalleled scientific program covering epidemiology, prevention, acute care, rehabilitation and recovery in 100s of sessions and oral posters.

19 Oct 2018

Loyola Medicine neurologist honored for showing exceptional support to Neurocritical Care Society

Loyola Medicine neurologist Michael Schneck, MD, is a 2018 recipient of a Presidential Citation from the Neurocritical Care Society in recognition of his extraordinary efforts on behalf of the society.

7 Oct 2018

Treating sleep apnea in stroke patients provides significant benefits

A large study has found that commencing treatment for sleep apnea as soon as possible after a stroke or a mini-stroke significantly improves speech impairment and other neurological symptoms as well as walking and other physical functioning.

11 Sep 2018

Daily use of aspirin does not reduce occurrence of major cardiovascular events, finds ARRIVE trial

The role of aspirin in preventing a first heart attack or stroke among people at moderate risk of heart disease remains unclear.

28 Aug 2018

Study: 40% of patients with atrial fibrillation may have unknown brain damage

Four out of ten patients with atrial fibrillation but no history of stroke or transient ischaemic attack have previously unknown brain damage, according to the first results of the Swiss Atrial Fibrillation Cohort Study presented today at ESC Congress 2018.

27 Aug 2018

Mono-antiplatelet therapy after aortic heart valve replacements may work as well as two drugs

Current treatment guidelines say patients who undergo minimally invasive aortic heart valve replacements should receive two antiplatelet drugs to reduce the risk of dangerous blood clots.

14 Aug 2018

Drug combination may prevent secondary stroke in certain patients, study shows

Results from an international clinical trial of more than 4880 participants, published in the New England Journal of Medicine, show that combining clopidogrel and aspirin following a small stroke or experiencing minor stroke symptoms decreases risk of a new stroke, heart attack or other ischemic event within 90 days.

17 May 2018

NewYork-Presbyterian shares information on stroke risk and prevention

Every 40 seconds someone in the U.S. has a stroke, and every four minutes, someone dies from a stroke, according to the U.S. Centers for Disease Control and Prevention (CDC).

2 May 2018

Study: Left atrial appendage closure during open heart surgery protects against brain infarctions

Closure of the left atrial appendage during heart surgery protects the brain, according to late-breaking research presented today in a Hot Line LBCT Session at ESC Congress. The results suggest that closure should be routinely added to open heart surgery.

28 Aug 2017

Insertable cardiac monitors reveal prevalence of undiagnosed atrial fibrillation in high risk patients

With the use of implanted cardiac monitors researchers found a substantial incidence (nearly 30 percent) of previously undiagnosed atrial fibrillation (AF) after 18 months in patients at high risk of both AF and stroke, according to a study published by JAMA Cardiology.

26 Aug 2017